Skip to main content

Table 1 Characteristics of study participants

From: Antihyperglycemic effect of short-term arginyl-fructose supplementation in subjects with prediabetes and newly diagnosed type 2 diabetes: randomized, double-blinded, placebo-controlled trial

  Placebo (n = 24) Test (n = 25)
Age (years) 58.3 ± 1.27 56.6 ± 1.98
Sex (male/female) (19/5) (19/6)
Weight (kg)   
 0 week 65.9 ± 2.25 70.3 ± 1.92
 6 week 65.3 ± 2.25** 69.67 ± 1.86**
BMI (kg/m2)   
 0 week 23.4 ± 0.67 24.9 ± 0.57
 6 week 23.2 ± 0.67** 24.7 ± 0.55**
WHR (cm/cm)   
 0 week 0.89 ± 0.01 0.92 ± 0.01
 6 week 0.89 ± 0.01 0.92 ± 0.01
Body fat (%)   
 0 week 23.4 ± 1.44 26.1 ± 1.45
 6 week 22.7 ± 1.49** 26.1 ± 1.48
Lean body mass (kg)   
 0 week 50.2 ± 1.55 51.9 ± 2.94
 6 week 50.1 ± 1.55 51.3 ± 1.57
Systolic BP   
 0 week 128.6 ± 2.67 129.5 ± 2.94
 6 week 124.5 ± 2.99 128.2 ± 2.17
Diastolic BP   
 0 week 77.9 ± 1.55 78.2 ± 1.85
 6 week 76.4 ± 1.70 78.2 ± 1.57
TEE (kcal/day)   
 0 week 2123 ± 232.52 2266 ± 273.43
 6 week 2140 ± 229.63* 2280 ± 280.27
TCI (kcal/day)   
 0 week 2241 ± 251.81 2288 ± 261.65
 6 week 2210 ± 261.45* 2266 ± 252.84*
Carbohydrate (%)   
 0 week 61.9 ± 0.64 61.3 ± 0.81
 6 week 61.8 ± 0.79 61.3 ± 0.77
Protein (%)   
 0 week 15.9 ± 0.38 16.0 ± 0.37
 6 week 15.8 ± 0.36 15.9 ± 0.38
Fat (%)   
 0 week 22.9 ± 1.10 23.4 ± 1.25
 6 week 23.1 ± 1.12 23.4 ± 0.87
  1. Data are shown as mean ± SEM
  2. p < 0.1, *p < 0.05, **p < 0.01, compared to 0 week, tested by paired t-test
  3. BMI Body mass index, BP Blood pressure, TCI Total calorie intake, TEE Total energy expenditure, WHR Waist-to-hip ratio